ArticleVaccine2026
Modification and validation of the teen vaccine hesitancy scale toward vaccines for adolescents.
Article in Vaccine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo modify an existing parent-administered Vaccine Hesitancy Scale to create a teen Vaccine Hesitancy Scale (tVHS) capturing vaccine hesitancy among adolescents.
methodsWe conducted a nationally representative survey of 725 parent-teen dyads to test and validate the tVHS. We performed exploratory factor analysis (EFA) to identify the latent structure of the tVHS, followed by confirmatory factor analysis (CFA) to confirm factor structure. We conducted structural equation modeling (SEM) to assess correlations between factors and vaccine intention (i.e., influenza/flu, HPV, COVID-19, and meningococcal vaccines). We ran logistic regression to examine the association between the tVHS scores and intentions to receive recommended adolescent vaccines.
resultsThe final teen vaccine hesitancy scale (tVHS) included 14 items capturing a three-factor structure: vaccine confidence (factor 1), perceived vaccine risks (factor 2), and lack of trust in government (factor 3). Factor 1 was correlated with intention to receive the HPV vaccine (β = -0.35, p < 0.01), flu vaccine (β = -0.32, p < 0.01), and meningococcal vaccine (β = -0.51, p < 0.001). Factors 2 and 3 were correlated with the intention to receive flu vaccine (β = -0.13, p < 0.05 and β = -0.25, p < 0.05, respectively) and COVID-19 vaccination (β = -0.14, p < 0.01 and β = -0.61, p < 0.001, respectively). The SEM model fit data well (RMSEA = 0.073, CFI = 0.965, TLI = 0.954, SRMR = 0.077). As tVHS scores increased, the percentage of adolescents who reported lower intention to receive recommended vaccines also increased, indicating good construct validity.
conclusionThe tVHS can be used to evaluate changes in vaccine hesitancy over time among adolescents and better guide programs and policies to improve adolescent vaccination uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.